Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2007
10/18/2007WO2007115990A1 Process for the preparation of pure irbesartan
10/18/2007WO2007115966A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/18/2007WO2007100880A8 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
10/18/2007WO2007084415A3 Compounds for the treatment of inflammatory disorders
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007WO2007075629A3 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/18/2007WO2007064345A3 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
10/18/2007WO2006087544A8 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
10/18/2007US20070244210 Piperazino Sensitisers
10/18/2007US20070244177 Enzyme inhibitors
10/18/2007US20070244170 Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity
10/18/2007US20070244159 including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), such as 1-(Benzo[d][1,3]dioxol-5-yl)-N-(2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, used for the treatment of genetic disorders such as cystic fibrosis, emphysema, hemochromatosis and protein C deficiency
10/18/2007US20070244140 Anilino-pyrimidine phenyl and benzothiophene analogs
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244137 Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes
10/18/2007US20070244136 Quinazoline Derivatives
10/18/2007US20070244126 small-molecules that can control the release of inflammatory mediators and inhibit leukocyte recruitment; antiinflammatory agents; [5-(5-Fluoro-4-methyl-1H-benzoimidazol-2-yl)-4-methyl-pyrimidin-2-yl]-[3-(1-methyl-piperidin-4-yl)-propyl]-amine
10/18/2007US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors
10/18/2007US20070244118 Cyclic Amide Derivative, and Its Production and Use
10/18/2007US20070244113 Compounds and therapeutical use thereof
10/18/2007US20070244094 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/18/2007US20070244092 Therapeutic Compounds
10/18/2007US20070244088 New Pyridine Analogues II
10/18/2007US20070244086 3-Phenyl-Pyrazole Derivatives as Modulators of the 5-Ht2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
10/18/2007DE69233686T2 Heteoaryl-Piperidine und Piperazine und ihre Anwendung als antipsychotisches und analgetisches Mittel Heteoaryl-piperidines and piperazines and their use as antipsychotic and analgesic agent
10/18/2007CA2654218A1 Process for the preparation of pure irbesartan
10/18/2007CA2649209A1 Enzyme inhibitors
10/18/2007CA2648529A1 Quinazolines for pdk1 inhibition
10/18/2007CA2648323A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007CA2648170A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
10/18/2007CA2648168A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/17/2007EP1845094A1 Method of tumor suppression and evaluation of anticancer agent based on gsk3 beta inhibitory effect
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1844019A2 Methode for the production of losartan
10/17/2007EP1844004A1 Quinazoline derivates as antiviral agents
10/17/2007EP1843820A1 Multicyclic bis-amide mmp inhibitors
10/17/2007EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007EP1218353B1 Quinazoline derivatives
10/17/2007CN101056872A Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
10/17/2007CN101056864A Method for preparing pyrimidine compound
10/17/2007CN101056632A Compounds and compositions as protein kinase inhibitors
10/17/2007CN101054372A Pyrimidine substituted benzenepropanoic acid derivative, its preparation method and use in curing polycystic kidney disease
10/17/2007CN100343338C Yellow anionic disazo dyes
10/17/2007CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/17/2007CN100343248C 溴化物及其晶体 Bromides and Crystal
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282511 Isatine derivatives with neurotrophic activity
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282498 Substituted fused pyrroleoximes and fused pyrazoleoximes
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007US7282495 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
10/16/2007US7282494 Heteroaryl diazacycloalkanes, their preparation and use
10/16/2007US7282469 Herbicides
10/16/2007CA2327253C Sulfonamide-containing indole compounds
10/16/2007CA2261829C Intermediates for the preparation of 2-imidazoline-5-ones
10/11/2007WO2007115190A2 System and method of converting a builders risk insurance policy to a homeowner's insurance policy
10/11/2007WO2007115182A2 Linear natriuretic peptide constructs
10/11/2007WO2007115174A2 System, methods, and instrumentation for image guided prostate treatment
10/11/2007WO2007114827A1 Substituted heterocyclic compounds and methods of use
10/11/2007WO2007114763A1 Sulphonamide derivates as modulators of the glucocorticoid receptor
10/11/2007WO2007114398A1 Pyrazole-type cyanine dye
10/11/2007WO2007114323A1 Aminopyrrolidine compound
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007113634A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
10/11/2007WO2007113261A1 Process for preparing heterocyclic derivatives
10/11/2007WO2007113260A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113256A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/11/2007WO2007113232A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007084135A9 Inhibitors of checkpoint kinases
10/11/2007WO2007058862A3 Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
10/11/2007WO2006123165A3 Pyrimidine derivatives as hsp90 inhibitors
10/11/2007WO2006086381A3 Hepatitis c virus inhibitors
10/11/2007US20070238882 Process for Preparing Nitrooxy Esters, Nitrooxy Thioesters Nitrooxy Carbonates and Nitrooxy Thiocarbinates, Intermediates Useful in Said Process and Preparation Thereof
10/11/2007US20070238876 Process for the preparation of aripiprazole
10/11/2007US20070238771 Indoles and benzoimidazoles as histamine H4 receptor modulators
10/11/2007US20070238765 Heterocyclic GABAA subtype selective receptor modulators
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007US20070238728 Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
10/11/2007US20070238724 3-(1-methylpiperidin-4-yl)-5-(1-naphthylsulfonyl)-1H-indazole, central nervous system disorder
10/11/2007US20070238699 Compounds for the treatment of proliferative disorders
10/11/2007CA2682846A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
10/11/2007CA2648443A1 Substituted heterocyclic compounds and methods of use
10/11/2007CA2648089A1 Process for preparing heterocyclic derivatives
10/11/2007CA2648087A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007CA2646755A1 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
10/11/2007CA2645959A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/10/2007EP1842845A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
10/10/2007EP1841760A2 Pyrimidine derivatives as kinase modulators and method of use
10/10/2007EP1841759A2 5-pyrrolidinylsulfonyl isatin derivatives
10/10/2007EP1841744A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
10/10/2007EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
10/10/2007EP1841737A1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/10/2007EP1841736A1 Indoles useful in the treatment of inflammation
10/10/2007EP1841735A1 Indoles useful in the treatment of inflammation